SK Biopharmaceuticals. (326030.KQ) Q1 2026 Earnings

Feb 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
236
727
1,219
1,711

Details

Expected EPS
438
Actual EPS
1,711
Surprise EPS
1,273
Surprise Percent
+290.53%

Description

⁨SK Biopharmaceuticals.⁩ (⁦326030.KQ⁩) has reported earnings of ⁦1,711⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts